Patents by Inventor Gabi M. Frei

Gabi M. Frei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230242883
    Abstract: Methods of ex-vivo culture of natural killer (NK) cells are provided and, more particularly, methods for enhancing propagation and/or functionality of NK cells by treating the cells with a nicotinamide or other nicotinamide moiety in combination with cytokines driving NK cell proliferation. Also envisioned are compositions comprising culture NK cells and therapeutic uses thereof.
    Type: Application
    Filed: April 6, 2023
    Publication date: August 3, 2023
    Applicant: Gamida Cell Ltd.
    Inventors: Tony PELED, Gabi M. FREI
  • Patent number: 9175266
    Abstract: Methods of ex-vivo culture of natural killer (NK) cells are provided and, more particularly, methods for enhancing propagation and/or functionality of NK cells by treating the cells with an aryl hydrocarbon antagonist in combination with cytokines driving NK cell proliferation. Also envisioned are compositions comprising cultured NK cells and therapeutic uses thereof.
    Type: Grant
    Filed: July 19, 2013
    Date of Patent: November 3, 2015
    Assignee: Gamida Cell Ltd.
    Inventors: Tony Peled, Gabi M. Frei
  • Publication number: 20140023626
    Abstract: Methods of ex-vivo culture of natural killer (NK) cells are provided and, more particularly, methods for enhancing propagation and/or functionality of NK cells by treating the cells with an aryl hydrocarbon antagonist in combination with cytokines driving NK cell proliferation. Also envisioned are compositions comprising cultured NK cells and therapeutic uses thereof.
    Type: Application
    Filed: July 19, 2013
    Publication date: January 23, 2014
    Inventors: Tony Peled, Gabi M. Frei
  • Publication number: 20130011376
    Abstract: Methods of ex-vivo culture of natural killer (NK) cells are provided and, more particularly, methods for enhancing propagation and/or functionality of NK cells by treating the cells with a nicotinamide or other nicotinamide moiety in combination with cytokines driving NK cell proliferation. Also envisioned are compositions comprising cultured NK cells and therapeutic uses thereof.
    Type: Application
    Filed: December 29, 2010
    Publication date: January 10, 2013
    Applicant: GAMIDA CELL LTD.
    Inventors: Tony Peled, Gabi M. Frei